Kathryn J. Collier serves as Executive at Regulus Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Kathryn J. Collier has executed 5 insider transactions totaling $17.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 25, 2024 involved purchasing 4,000 shares valued at $7.3K.
Kathryn J. Collier currently holds 6,740 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathryn J. Collier has been a net buyer of RGLS stock. They have purchased $17.3K and sold $0 worth of shares.
Kathryn J. Collier's most recent insider trade was on Jul 25, 2024, when they purchased 4,000 shares at $1.82 per share.
Get notified when new Form 4 filings are submitted
| $1.41 |
| Discretionary |
| Nov 12, 2018 | RGLS | $0 | Award | 16,874 | $N/A | Discretionary |
| Jun 5, 2018 | RGLS | $5.7K | Award | 7,695 | $0.74 | Discretionary |
| Apr 14, 2018 | RGLS | $38.5K | Award | 60,234 | $0.64 | Discretionary |